In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...

In little more than five years, German biotechnology company YUMAB (a phonetic play on HUMAB (human monoclonal antibody ... fully human mAb drug (AbbVie’s Humira (adalimumab)), fully human ...

Examples of FDA-approved therapeutic monoclonal antibodies include trastuzumab (Herceptin) for breast cancer, adalimumab (Humira) for rheumatoid arthritis, and rituximab (Rituxan) for non-Hodgkin's ...

These are cheaper versions of biotech drugs made from living cells ... the Cordavis announcement was no accident. It came just as Humira, the highest grossing drug of all time, was set to start ...